We are live on ! Find out more
CTXR icon

Citius Pharmaceuticals
CTXR

39 hedge funds and large institutions have $19.3M invested in Citius Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 12 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,100% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 1

945% more capital invested

Capital invested by funds: $1.85M → $19.3M (+$17.5M)

425% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 4

77% more funds holding

Funds holding: 22 → 39 (+17)

0.2% more ownership

Funds ownership: 0.13% → 0.33% (+0.2%)

Holders
39
Holders Change
+17
Holders Change %
+77.27%
% of All Funds
0.68%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
12
Reduced
1
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$6.87M
2
BlackRock
BlackRock
New York
+$3.07M
3
Renaissance Technologies
Renaissance Technologies
New York
+$1.54M
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$1.13M
5
SM
Sabby Management
Florida
+$500K

Top Sellers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
-$151K
2
FIG
Freed Investment Group
Massachusetts
-$22.1K
3
TSS
Two Sigma Securities
New York
-$21K
4
WAM
Warberg Asset Management
Illinois
-$20K
5
CHA
Cooper/Haims Advisors
New York
-$10K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$9.02M +$6.87M +172,444 +571%
BlackRock
2
BlackRock
New York
$3.43M +$3.07M +77,146 New
Renaissance Technologies
3
Renaissance Technologies
New York
$1.76M +$1.54M +38,713 +4,549%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$1.52M +$1.13M +28,370 +489%
SM
5
Sabby Management
Florida
$559K +$500K +12,560 New
Northern Trust
6
Northern Trust
Illinois
$396K +$231K +5,809 +189%
HighTower Advisors
7
HighTower Advisors
Illinois
$303K – – –
Millennium Management
8
Millennium Management
New York
$299K +$252K +6,323 +1,573%
UBS Group
9
UBS Group
Switzerland
$201K +$17.2K +433 +11%
IA
10
Inspire Advisors
Idaho
$197K +$176K +4,431 New
Susquehanna International Group
11
Susquehanna International Group
Pennsylvania
$175K +$156K +3,923 New
Osaic Holdings
12
Osaic Holdings
Arizona
$131K +$34.2K +860 +41%
Marshall Wace
13
Marshall Wace
United Kingdom
$123K +$110K +2,755 New
LP
14
LMR Partners
United Kingdom
$114K +$102K +2,558 New
GCP
15
GSA Capital Partners
United Kingdom
$102K +$37.7K +946 +70%
Jane Street
16
Jane Street
New York
$99K +$88.2K +2,214 New
Bank of New York Mellon
17
Bank of New York Mellon
New York
$94K +$83.7K +2,101 New
TRCT
18
Tower Research Capital (TRC)
New York
$90K +$80.2K +2,014 New
MIM
19
Miller Investment Management
Pennsylvania
$89K – – –
HGWM
20
Horst & Graben Wealth Management
Oregon
$88K +$79K +1,984 New
Charles Schwab
21
Charles Schwab
California
$77K +$68.5K +1,721 New
Capstone Investment Advisors
22
Capstone Investment Advisors
New York
$74K +$66.1K +1,659 New
Morgan Stanley
23
Morgan Stanley
New York
$71K +$63.7K +1,600 New
CCM
24
Conway Capital Management
California
$53.4K +$47.8K +1,200 New
Citadel Advisors
25
Citadel Advisors
Florida
$50K +$14.5K +364 +48%
1
2

CTXR Hedge Fund Activity: Q1 2021 in Review

39 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Citius Pharmaceuticals (CTXR) for Q1 2021, worth a combined $19.3M — up 945% from $1.85M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new CTXR positions and 4 closed out — a net gain of 17 holders — while 12 added to existing stakes and 1 trimmed.

The largest buyer was Vanguard Group, adding an estimated $6.87M. The largest seller was Virtu Financial, exiting entirely with an estimated $151K sold.

  • 39 institutional investors held Citius Pharmaceuticals (CTXR) as of Q1 2021, up from 22 in Q4 2020.
  • Funds reported $19.3M of Citius Pharmaceuticals stock for Q1 2021, up 945% quarter-over-quarter.
  • 21 funds opened new Citius Pharmaceuticals positions in Q1 2021 and 4 closed out, a net change of +17 holders.
  • The largest Citius Pharmaceuticals buyer in Q1 2021 was Vanguard Group, an estimated $6.87M added.
  • The largest Citius Pharmaceuticals seller in Q1 2021 was Virtu Financial, an estimated $151K sold.

Based on aggregated 13F filings for Q1 2021.